ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Liver Allograft Hepatitis and Graft Loss After Hepatitis C Clearance.

D. Bruno, S. Brown, S. Hanish, J. LaMattina, W. Hutson, S. Kottilil, W. Twadell, R. Barth.

Surgery, University of Maryland School of Medicine, Baltimore, MD

Meeting: 2017 American Transplant Congress

Abstract number: D223

Keywords: Graft failure, Hepatitis C, Liver transplantation

Session Information

Date: Tuesday, May 2, 2017

Session Name: Poster Session D: Liver: Viral Hepatitis

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Related Abstracts
  • An Investigation of Biopsy-Proven De Novo Autoimmune Hepatitis After Hepatitis C Clearance with Direct Acting Antivirals in Liver Transplant Patients.
  • Efficacy of Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation

Successful HCV therapies should improve inferior outcomes of liver transplantation (LT) for HCV cirrhosis. We hypothesize certain patients may be predisposed to heterologous immunity that targets hepatocytes that persist post viral clearance. We report a case series of progressive hepatitis and graft loss with undetectable viral load after LT.

Methods:

IRB-approved retrospective review from 3 liver transplant patients in 2015-6.

Results:

Case 1 – A 39 y/o male was diagnosed with Hepatitis C cirrhosis in 11/2014. He completed treatment and achieved SVR. He underwent LT. He did well but 4 months later was found to have increasing bilirubin. Biopsies showed biliary disease with cholestasis, interface hepatitis, and bile duct proliferation. The hepatitis C viral load remained undetectable. The patient succumbed to liver failure.

Case 2 – A 62 y/o male with hepatitis C cirrhosis and hepatocellular carcinoma was treated pretransplant and achieved SVR. The patient did well after LT and was treated for mild acute rejection. Despite this he continued to have increased bilirubin. Repeated biopsies showed cholestasis with duct damage and spotty confluent necrosis. His viral load was undetectable. The patient succumbed to liver failure.

Case 3 – A 64 y/o male with hepatitis C cirrhosis spontaneously cleared virus prior to receiving an LT. He had an uncomplicated immediate post-operative course. He had increasing LFTs and a biopsy 3 months after transplant was suggestive of recurrent hepatitis C. He had multiple biopsies for increased hepatic enzymes and increased bilirubin that showed portal and periportal (interface) hepatitis with lymphoid aggregate formation. The HCV viral load remained negative. He succumbed to liver failure 6 months after transplant.

Conclusion:

Histologic evidence and clinical course of fibrosing cholestatic hepatitis and graft loss were observed in a series of liver transplant patients cleared of HCV. This series may support the continued presence of deleterious cellular immune responses to hepatocytes after successful HCV therapy.

CITATION INFORMATION: Bruno D, Brown S, Hanish S, LaMattina J, Hutson W, Kottilil S, Twadell W, Barth R. Liver Allograft Hepatitis and Graft Loss After Hepatitis C Clearance. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Bruno D, Brown S, Hanish S, LaMattina J, Hutson W, Kottilil S, Twadell W, Barth R. Liver Allograft Hepatitis and Graft Loss After Hepatitis C Clearance. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/liver-allograft-hepatitis-and-graft-loss-after-hepatitis-c-clearance/. Accessed January 16, 2021.

« Back to 2017 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.